Anti-obesity pharmacotherapy in adults with chronic kidney disease
E Taber-Hight, A Gilmore, AN Friedman - Kidney International, 2024 - Elsevier
Obesity is a leading risk factor for the development and progression of kidney disease and a
major barrier to optimal management of patients with chronic kidney disease. While in the …
major barrier to optimal management of patients with chronic kidney disease. While in the …
Management of patients with kidney disease undergoing bariatric surgery: a multidisciplinary approach
Bariatric surgery is increasingly recognized as a safe and effective treatment for obesity in
patients with chronic kidney disease (CKD), including stages 4, 5, and 5D (on dialysis) …
patients with chronic kidney disease (CKD), including stages 4, 5, and 5D (on dialysis) …
Obstacles and opportunities in managing coexisting obesity and CKD: report of a scientific workshop cosponsored by the national kidney foundation and the obesity …
AN Friedman, PR Schauer, S Beddhu, H Kramer… - American Journal of …, 2022 - Elsevier
The National Kidney Foundation (NKF) and The Obesity Society (TOS) cosponsored a
multispecialty international workshop in April 2021 to advance the understanding and …
multispecialty international workshop in April 2021 to advance the understanding and …
[HTML][HTML] Interplay between metabolic dysfunction-associated fatty liver disease and chronic kidney disease: Epidemiology, pathophysiologic mechanisms, and …
P Theofilis, A Vordoni, RG Kalaitzidis - World Journal of …, 2022 - ncbi.nlm.nih.gov
The recently proposed nomenclature change from non-alcoholic fatty liver disease to
metabolic dysfunction-associated fatty liver disease (MAFLD) has resulted in the reappraisal …
metabolic dysfunction-associated fatty liver disease (MAFLD) has resulted in the reappraisal …
Changes in renal blood flow after surgically induced weight loss: can bariatric surgery halt the progression of chronic kidney disease?
DR Funes, DG Blanco, EL Menzo, S Szomstein… - Surgery for Obesity and …, 2024 - Elsevier
Background We previously demonstrated how kidney injury in patients with morbid obesity
can be reversed by bariatric surgery (BaS). Objective (s) Based on previous experience, we …
can be reversed by bariatric surgery (BaS). Objective (s) Based on previous experience, we …
Effects of bariatric surgery on renal function: a retrospective cohort study comparing one-year outcomes between one-anastomosis gastric bypass and Roux-en-Y …
VK Ivano, M Hatto, F Teramoto, PRA Macedo… - Sao Paulo Medical …, 2024 - SciELO Brasil
ABSTRACT BACKGROUND: Evidence on the effect of one-anastomosis gastric bypass
(OAGB) on renal function is limited. OBJECTIVE: To compare the evolution of estimated …
(OAGB) on renal function is limited. OBJECTIVE: To compare the evolution of estimated …
[PDF][PDF] VICTOR KENZO IVANO
ACDEIS AO, Y DE ROUX - repositorio.unicamp.br
Introduction: Obesity is a multifactorial disease associated with multiple systemic
consequences. In addition to metabolic syndrome, cardiovascular risk, and association with …
consequences. In addition to metabolic syndrome, cardiovascular risk, and association with …